GLSI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 51.67%

Insider Buying (Last 12 Months): $2,788,956.50

Insider Selling (Last 12 Months): $0.00

Greenwich LifeSciences Insider Trading History Chart

Greenwich LifeSciences Share Price & Price History

^$9.35

▲ +0.09 (0.97%)

As of 04/2/2025 05:00 PM ET

Days: 30 | 90 | 365

Greenwich LifeSciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/10/2025	Snehal S. Patel	CEO	Buy	2,500	$12.51	$31,275.00	5,552,502
1/7/2025	Snehal S. Patel	CEO	Buy	1,800	$13.75	$24,750.00	5,550,002
1/2/2025	Snehal S. Patel	CEO	Buy	2,000	$11.97	$23,940.00	5,543,702
12/30/2024	Snehal S. Patel	CEO	Buy	3,200	$11.12	$35,584.00	5,539,302
11/21/2024	Jaye Thompson	VP	Buy	1,000	$12.91	$12,910.00	264,148
9/26/2024	Snehal S. Patel	CEO	Buy	1,500	$14.63	$21,945.00	5,536,102
8/12/2024	Jaye Thompson	VP	Buy	800	$13.85	$11,080.00	263,148
8/5/2024	Snehal S. Patel	CEO	Buy	5,500	$13.18	$72,490.00	5,532,602
8/2/2024	Jaye Thompson	VP	Buy	1,000	$15.15	$15,150.00	262,348
7/23/2024	Snehal S. Patel	CEO	Buy	1,500	$15.89	$23,835.00	5,527,102
7/18/2024	Jaye Thompson	VP	Buy	1,000	$16.00	$16,000.00	261,348
6/13/2024	Snehal S. Patel	CEO	Buy	174,825	$14.30	$2,499,997.50	5,525,602
4/1/2024	Snehal S. Patel	CEO	Buy	3,000	$19.08	$57,240.00	5,350,777
3/22/2024	Snehal S. Patel	CEO	Buy	2,500	$19.98	$49,950.00	5,347,777
3/20/2024	Snehal S. Patel	CEO	Buy	1,500	$17.68	$26,520.00	5,345,277
3/4/2024	Snehal S. Patel	CEO	Buy	4,100	$13.03	$53,423.00	5,340,277
2/15/2024	Snehal S. Patel	CEO	Buy	12,700	$11.07	$140,589.00	5,325,377
11/10/2023	Snehal S. Patel	CEO	Buy	5,000	$10.17	$50,850.00	5,312,677
11/3/2023	Snehal S. Patel	CEO	Buy	3,500	$9.11	$31,885.00	5,307,677
10/27/2023	Jaye Thompson	VP	Buy	500	$8.57	$4,285.00	260,348
10/25/2023	Snehal S. Patel	CEO	Buy	2,500	$7.91	$19,775.00	5,301,677
10/10/2023	Snehal S. Patel	CEO	Buy	1,000	$9.07	$9,070.00	5,299,177
10/4/2023	Snehal S. Patel	CEO	Buy	2,000	$8.63	$17,260.00	5,298,177
9/26/2023	Jaye Thompson	VP	Buy	600	$8.71	$5,226.00	259,848
9/19/2023	Snehal S. Patel	CEO	Buy	4,000	$8.95	$35,800.00	5,296,177
9/19/2023	Snehal S. Patel	CEO	Buy	4,000	$8.95	$35,800.00	5,296,177
9/11/2023	Snehal S. Patel	CEO	Buy	1,000	$9.48	$9,480.00	5,292,177
8/22/2023	Snehal S. Patel	CEO	Buy	1,000	$9.97	$9,970.00	5,291,177
8/4/2023	Snehal S. Patel	CEO	Buy	2,000	$10.55	$21,100.00	5,290,177
7/21/2023	Snehal S. Patel	CEO	Buy	1,000	$9.20	$9,200.00	5,288,177
7/13/2023	Jaye Thompson	VP	Buy	250	$9.49	$2,372.50	259,248
5/17/2023	Snehal S. Patel	CEO	Buy	1,000	$11.69	$11,690.00	5,287,177
4/28/2023	Jaye Thompson	VP	Buy	250	$11.22	$2,805.00	258,998
4/18/2023	Snehal S. Patel	CEO	Buy	2,000	$11.12	$22,240.00	5,279,177
4/11/2023	Jaye Thompson	VP	Buy	1,000	$11.87	$11,870.00	258,745
4/11/2023	Snehal S. Patel	CEO	Buy	5,000	$12.42	$62,100.00	5,271,177
3/15/2023	Jaye Thompson	VP	Buy	250	$12.71	$3,177.50	257,745
3/10/2023	Snehal S. Patel	CEO	Buy	1,000	$12.12	$12,120.00	2,737,486
2/24/2023	Jaye Thompson	VP	Buy	250	$15.39	$3,847.50	257,495
2/17/2023	Snehal S. Patel	CEO	Buy	600	$16.53	$9,918.00	2,736,486
2/10/2023	Snehal S. Patel	CEO	Buy	1,000	$18.68	$18,680.00	2,735,886
2/3/2023	Jaye Thompson	VP	Buy	250	$20.84	$5,210.00	257,245
1/27/2023	Jaye Thompson	VP	Buy	250	$19.20	$4,800.00	256,995
1/27/2023	Snehal S. Patel	CEO	Buy	2,000	$19.35	$38,700.00	2,734,886
1/20/2023	Snehal S. Patel	CEO	Buy	1,500	$17.37	$26,055.00	2,732,886
1/13/2023	Jaye Thompson	VP	Buy	250	$16.50	$4,125.00	256,745
1/6/2023	Snehal S. Patel	CEO	Buy	1,500	$15.18	$22,770.00	2,731,386
12/16/2022	Jaye Thompson	VP	Buy	250	$12.94	$3,235.00	256,495
12/16/2022	Snehal S. Patel	CEO	Buy	1,000	$13.01	$13,010.00	2,725,886
12/9/2022	Snehal S. Patel	CEO	Buy	2,000	$13.11	$26,220.00	2,724,886
12/2/2022	Jaye Thompson	VP	Buy	250	$13.98	$3,495.00	256,245
12/2/2022	Snehal S. Patel	CEO	Buy	1,000	$13.84	$13,840.00	2,722,886
11/2/2022	Snehal S. Patel	CEO	Buy	2,000	$8.79	$17,580.00	2,721,886
10/14/2022	Snehal S. Patel	CEO	Buy	3,000	$9.75	$29,250.00	2,719,886
10/7/2022	Snehal S. Patel	CEO	Buy	2,000	$9.72	$19,440.00	2,716,886
10/7/2022	Snehal S. Patel	CEO	Buy	2,000	$9.72	$19,440.00	2,716,886
9/29/2022	Snehal S. Patel	CEO	Buy	1,000	$9.23	$9,230.00	2,713,886
6/24/2022	Snehal S. Patel	CEO	Buy	22,535	$9.13	$205,744.55	2,706,421
6/16/2022	Snehal S. Patel	CEO	Buy	8,000	$7.13	$57,040.00	2,683,886
6/14/2022	Snehal S. Patel	CEO	Buy	12,000	$7.91	$94,920.00	2,675,886
6/9/2022	Snehal S. Patel	CEO	Buy	4,500	$10.90	$49,050.00	1,243,453
6/7/2022	Snehal S. Patel	CEO	Buy	6,000	$8.55	$51,300.00	1,238,953
6/2/2022	Snehal S. Patel	CEO	Buy	6,774	$7.38	$49,992.12	1,223,703
4/25/2022	Frank Joseph Daugherty	Insider	Buy	1,000	$16.25	$16,250.00	90,121
4/21/2022	Snehal S. Patel	CEO	Buy	6,000	$16.09	$96,540.00	1,216,929
4/19/2022	Jaye Thompson	VP	Buy	500	$16.74	$8,370.00	255,995
4/19/2022	Snehal S. Patel	CEO	Buy	6,000	$16.74	$100,440.00	1,210,929

See Full Table

SEC Filings (Institutional Ownership Changes) for Greenwich LifeSciences (NASDAQ:GLSI)

4.16% of Greenwich LifeSciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Greenwich LifeSciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Bank of America Corp DE	7,262	$82K	0.0%	+22.3%	0.055%
2/14/2025	Northern Trust Corp	87,423	$0.98M	0.0%	+17.3%	0.665%
2/13/2025	Barclays PLC	9,648	$0.11M	0.0%	+12.7%	0.073%
2/13/2025	Renaissance Technologies LLC	22,700	$0.26M	0.0%	-30.2%	0.173%
2/13/2025	Wells Fargo & Company MN	2,847	$32K	0.0%	+54.8%	0.022%
2/12/2025	Brown Brothers Harriman & Co.	4,000	$45K	0.0%	N/A	0.030%
2/12/2025	JPMorgan Chase & Co.	7,061	$79K	0.0%	+172.0%	0.054%
12/10/2024	Garden State Investment Advisory Services LLC	17,600	$0.25M	0.1%	N/A	0.134%
11/19/2024	Barclays PLC	8,560	$0.12M	0.0%	+323.3%	0.065%
11/16/2024	Geode Capital Management LLC	133,550	$1.92M	0.0%	+4.6%	1.016%
11/15/2024	Barclays PLC	8,560	$0.12M	0.0%	+323.3%	0.065%
11/15/2024	State Street Corp	71,408	$1.03M	0.0%	+4.4%	0.543%
11/15/2024	Garden State Investment Advisory Services LLC	17,600	$0.25M	0.1%	N/A	0.134%
11/12/2024	Charles Schwab Investment Management Inc.	16,455	$0.24M	0.0%	-10.8%	0.125%
8/1/2024	Rhumbline Advisers	6,799	$0.12M	0.0%	N/A	0.053%
7/26/2024	Bank of New York Mellon Corp	15,295	$0.26M	0.0%	N/A	0.119%
5/10/2024	Vanguard Group Inc.	223,102	$4.45M	0.0%	+0.6%	1.732%
2/14/2023	683 Capital Management LLC	11,700	$0.18M	0.0%	N/A	0.091%
11/15/2022	Pura Vida Investments LLC	19,667	$0.18M	0.0%	N/A	0.153%
8/8/2022	Walleye Capital LLC	10,656	$90K	0.0%	N/A	0.082%
4/29/2022	Nisa Investment Advisors LLC	7,200	$0.14M	0.0%	N/A	0.056%
2/7/2022	SG Americas Securities LLC	4,395	$0.11M	0.0%	N/A	0.034%
11/15/2021	Invesco Ltd.	148,087	$5.79M	0.0%	-47.1%	1.138%
11/15/2021	Tibra Equities Europe Ltd	12,700	$0.50M	0.8%	N/A	0.098%
11/12/2021	OLD Mission Capital LLC	7,358	$0.29M	0.0%	N/A	0.057%
11/12/2021	Geode Capital Management LLC	56,919	$2.22M	0.0%	+8.6%	0.437%
8/17/2021	Invesco Ltd.	280,062	$12.59M	0.0%	N/A	2.171%
8/16/2021	California State Teachers Retirement System	5,588	$0.25M	0.0%	N/A	0.043%
8/16/2021	Charles Schwab Investment Management Inc.	9,819	$0.44M	0.0%	N/A	0.076%
8/16/2021	State Street Corp	50,212	$2.26M	0.0%	N/A	0.389%
8/16/2021	Nuveen Asset Management LLC	6,392	$0.29M	0.0%	N/A	0.050%
8/13/2021	Northern Trust Corp	12,098	$0.54M	0.0%	N/A	0.094%
8/13/2021	Geode Capital Management LLC	52,395	$2.35M	0.0%	+262.3%	0.406%
8/13/2021	Vanguard Group Inc.	121,418	$5.46M	0.0%	+14.3%	0.941%
8/12/2021	State of Wisconsin Investment Board	5,200	$0.23M	0.0%	N/A	0.040%
8/12/2021	JPMorgan Chase & Co.	4,789	$0.22M	0.0%	N/A	0.037%
8/11/2021	Bank of New York Mellon Corp	6,664	$0.30M	0.0%	N/A	0.052%
8/11/2021	BlackRock Inc.	217,748	$9.79M	0.0%	+242.7%	1.688%
8/11/2021	Deutsche Bank AG	2,396	$0.11M	0.0%	N/A	0.019%
8/10/2021	Citigroup Inc.	1,611	$72K	0.0%	+212.8%	0.012%
8/2/2021	New York State Common Retirement Fund	3,500	$0.16M	0.0%	N/A	0.027%
5/18/2021	Millennium Management LLC	19,450	$0.66M	0.0%	+169.7%	0.000%
5/18/2021	Citadel Advisors LLC	7,114	$0.24M	0.0%	N/A	0.000%
5/17/2021	Royal Bank of Canada	2,800	$95K	0.0%	N/A	0.000%
5/17/2021	HRT Financial LP	10,952	$0.37M	0.0%	N/A	0.000%
5/12/2021	Geode Capital Management LLC	14,463	$0.49M	0.0%	+106.0%	0.000%
5/7/2021	BlackRock Inc.	63,540	$2.17M	0.0%	+7.2%	0.000%
4/30/2021	Creative Planning	7,351	$0.25M	0.0%	+4.4%	0.000%
4/29/2021	SkyOak Wealth LLC	7,405	$0.29M	0.1%	-8.6%	0.000%
2/9/2021	Wells Fargo & Company MN	1,134	$41K	0.0%	N/A	0.000%

Data available starting January 2016

See Full Table

Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.

Today's Range

Now: $9.35

$9.25

$10.91

50 Day Range

MA: $11.95

$9.26

$13.28

52 Week Range

Now: $9.35

$9.06

$18.75

Volume

322,663 shs

Average Volume

36,768 shs

Market Capitalization

$122.91 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.69

Who are the company insiders with the largest holdings of Greenwich LifeSciences?: Greenwich LifeSciences' top insider shareholders include:
Snehal Patel (CEO)
Jaye Thompson (VP)
Learn More about top insider investors at Greenwich LifeSciences.